Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00058006
Status:
COMPLETED
Last Update Posted:
2012-06-11
First Post:
2003-04-07
Brief Title:
Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
Sponsor:
Northwestern University
Organization:
Northwestern University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lung Cancer |
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| stage I non-small cell lung cancer | View |
| stage I squamous cell carcinoma of the hypopharynx | View |
| stage I squamous cell carcinoma of the larynx | View |
| stage I squamous cell carcinoma of the lip and oral cavity | View |
| stage I squamous cell carcinoma of the nasopharynx | View |
| stage I squamous cell carcinoma of the oropharynx | View |
| stage I squamous cell carcinoma of the paranasal sinus and nasal cavity | View |
| stage II squamous cell carcinoma of the hypopharynx | View |
| stage II squamous cell carcinoma of the larynx | View |
| stage II squamous cell carcinoma of the lip and oral cavity | View |
| stage II squamous cell carcinoma of the nasopharynx | View |
| stage II squamous cell carcinoma of the oropharynx | View |
| stage II squamous cell carcinoma of the paranasal sinus and nasal cavity | View |
| salivary gland squamous cell carcinoma | View |
| stage I salivary gland cancer | View |
| stage II salivary gland cancer | View |